Werner F. Blum, MD, PhD

Eli Lilly and Company
Lilly Diabetes
Papers:
Ten Years After the United States Food and Drug Administration (US FDA) Approval of GH Treatment for Children with Idiopathic Short Stature (ISS): Who is Being Treated and What is the Response to Treatment?
Ten-Year Change in Quality of Life in Patients with Childhood and Adult Onset Growth Hormone Deficiency in the Hypopituitary Control and Complications Study (HypoCCS)
FP20-5 Development of Multiple Pituitary Hormone Deficiencies (MPHD) in Pediatric Patients Originally Diagnosed with Isolated GH Deficiency (IGHD) due to Organic Causes